BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 9860107)

  • 1. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.
    Chiuccariello L; Cooke RG; Miler L; Levitan RD; Baker GB; Kish SJ; Kolla NJ; Rusjan PM; Houle S; Wilson AA; Meyer JH
    Int J Neuropsychopharmacol; 2015 Aug; 19(1):. PubMed ID: 26316187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved statistical analysis of moclobemide dose effects on panic disorder treatment.
    Ross DC; Klein DF; Uhlenhuth EH
    Eur Arch Psychiatry Clin Neurosci; 2010 Apr; 260(3):243-8. PubMed ID: 19936819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.
    Rakic Ignjatovic A; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
    Br J Clin Pharmacol; 2009 Feb; 67(2):199-208. PubMed ID: 19076986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral linezolid on the pressor response to intravenous tyramine.
    Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
    Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity.
    Isbister GK; Hackett LP; Dawson AH; Whyte IM; Smith AJ
    Br J Clin Pharmacol; 2003 Oct; 56(4):441-50. PubMed ID: 12968990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide: therapeutic use and clinical studies.
    Bonnet U
    CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.
    Bonnet U
    CNS Drug Rev; 2002; 8(3):283-308. PubMed ID: 12353059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
    Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical pharmacology of moclobemide. A review of published studies.
    Burkard WP; Da Prada M; Keller HH; Kettler R; Haefely W
    Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
    Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
    Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
    Dingemanse J; Hussain Y; Korn A
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.
    Korn A; Wagner B; Moritz E; Dingemanse J
    Eur J Clin Pharmacol; 1996; 49(4):273-8. PubMed ID: 8857072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
    Simpson GM; Gratz SS
    Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
    Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
    Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
    Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.